Clinical Trial Update: Activated Protein C and Corticosteroids for Human Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating activated protein C in combination with corticosteroids for septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Corticosteroids (corticosteroids)
• Drotrecogin alfa (activated) (drotrecogin alfa (activated))

Snippet

Sponsor: University of Versailles | Conditions: Septic Shock | Phase 3 | Status: COMPLETED